Jonathan Siegel

Jonathan Siegel

Chief Executive Officer bij OPY ACQUISITION CORP. I

Vermogen: 6 294 $ op 31-03-2024

50 jaar
Health Technology
Finance
Consumer Services

Profiel

Jonathan Blair Siegel is the founder of JBS Healthcare Ventures LLC, which was founded in 2017.
He is currently the Chief Executive Officer of JBS Healthcare Ventures LLC.
He is also currently the Chairman & Chief Executive Officer of OPY Acquisition Corp.
I since 2021.
Additionally, he holds the position of Independent Director at Sol-Gel Technologies Ltd., Jaguar Health, Inc., Napo Therapeutics SpA, and Napo Pharmaceuticals, Inc. since 2018.
Mr. Siegel's former positions include being an Associate Director-Pharmaceutical at Bear, Stearns & Co., Inc. from 2003 to 2005, a Director at AMAG Pharma USA, Inc. in 2013, a Partner & Head-Healthcare Sector at Kingdon Capital Management LLC from 2011 to 2017, and a Portfolio Manager at S.A.C.
Capital Advisors LP from 2005 to 2010.
He also worked as a Research Associate at Novartis Corp., a Research Assistant at Tufts University, a Research Associate at Beth Israel Deaconess Medical Center, Inc. from 1994 to 1997, a Research Associate-Novartis Center at Harvard Medical School, and a Research Associate at Dresdner Kleinwort Wasserstein Group, Inc.Mr. Siegel's education includes an undergraduate degree from Tufts University in 1995 and an MBA from Columbia Business School in 1999.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
14-08-2023 69 933 ( 0.03% ) 6 294 $ 31-03-2024

Actieve functies van Jonathan Siegel

BedrijvenFunctieBegin
JAGUAR HEALTH, INC. Director/Board Member 29-03-2018
SOL-GEL TECHNOLOGIES LTD. Director/Board Member 13-09-2018
OPY ACQUISITION CORP. I Chief Executive Officer 01-06-2021
Director/Board Member 01-03-2018
Chief Executive Officer 01-10-2017
Director/Board Member 01-03-2018
Alle actieve functies van Jonathan Siegel

Eerdere bekende functies van Jonathan Siegel

BedrijvenFunctieEinde
Portfolio Manager-Equities 01-01-2017
Analyst-Equity 31-12-2010
Corporate Officer/Principal 01-12-1997
░░░░ ░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ervaring van Jonathan Siegel in detail bekijken

Opleiding van Jonathan Siegel

Tufts University Undergraduate Degree
Columbia Business School Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Jonathan Siegel in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
SOL-GEL TECHNOLOGIES LTD.

Health Technology

JAGUAR HEALTH, INC.

Health Technology

Bedrijven in privébezit11

Finance

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Services

Dresdner Kleinwort Wasserstein Group, Inc.

Health Technology

Finance

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Jonathan Siegel